Guangzhou, Guangdong, China Related Funds
| Fund Name | Location |
| 33entrepreneurs | Aquitaine, Bordeaux, France |
| Apsara Investments | Central, Central Region, Singapore |
| CTW Venture Partners | Dunwoody, Georgia, United States |
| Godavari Biorefineries | India, Maharashtra, Mumbai |
| Goldfinch Partners | Seattle, United States, Washington |
| Guidewire Group | California, Redwood City, United States |
| Kestrel IDM | - |
| Leap Wireless | California, San Diego, United States |
| MI Care | - |
| Moscar Capital | England, London, United Kingdom |
| Nebraska Department of Economic Development | Lincoln, Nebraska, United States |
| New World Angels | Boca Raton, Florida, United States |
| Rotunda Capital Partners | Bethesda, Maryland, United States |
| Sabby Capital | New Jersey, United States, Upper Saddle River |
| Startup Farm | Brazil, São Paulo, São Paulo |
| Thuasne | - |
| Trestle Partners | New York, New York, United States |
| Wangdao Youxian Gongsi | China, Hong Kong, Hong Kong Island |
| Yingxue Ziben | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bioblue Technology | 07 Jul 2022 | Guangzhou, Guangdong, China | |||
Magpie Pharmaceuticals | $14M | 20 Apr 2020 | Yuexiu District, Guangdong Province, China | ||
Bainian Yihao | $23M | 08 Apr 2019 | Qingyang District, Sichuan | ||
Forevergen | 01 Apr 2017 | Guangzhou, Guangdong, China | |||
HEAS BioTech | 01 Mar 2017 | Guangzhou, Guangdong, China | |||
Qiji Yiyao | $463K | 14 Apr 2014 | Yuexiu District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bioblue Technology | 07 Jul 2022 | Guangzhou, Guangdong, China | |||
Magpie Pharmaceuticals | $14M | 20 Apr 2020 | Yuexiu District, Guangdong Province, China | ||
Bainian Yihao | $23M | 08 Apr 2019 | Qingyang District, Sichuan | ||
Forevergen | 01 Apr 2017 | Guangzhou, Guangdong, China | |||
HEAS BioTech | 01 Mar 2017 | Guangzhou, Guangdong, China | |||
Qiji Yiyao | $463K | 14 Apr 2014 | Yuexiu District, Guangdong Province, China |
